Hyperphosphataemia in chronic renal failure patients

Active Ingredient: Lanthanum

Indication for Lanthanum

Population group: only adults (18 years old or older)
Therapeutic intent: Curative procedure

Lanthanum is indicated in adult patients as a phosphate binding agent for use in the control of hyperphosphataemia in chronic renal failure patients on haemodialysis or continuous ambulatory peritoneal dialysis (CAPD).

Lanthanum is also indicated in adult patients with chronic kidney disease not on dialysis with serum phosphate levels ≥1.78 mmol/L in whom a low phosphate diet alone is insufficient to control serum phosphate levels.

For this indication, competent medicine agencies globally authorize below treatments:

750 mg daily for 2-3 weeks and thereafter 750-3000 mg daily

For:

Dosage regimens

Oral, 750 milligrams lanthanum, divided daily, over the duration of 2 to 3 weeks. Afterwards, oral, between 750 milligrams lanthanum and 3,000 milligrams lanthanum, divided daily.

Detailed description

Serum phosphate levels should be monitored and the dose of lanthanum titrated every 2-3 weeks until an acceptable serum phosphate levels is reached, with regular monitoring thereafter.

Control of serum phosphate level has been demonstrated at doses starting from 750 mg per day. The maximum dose studied in clinical trials, in a limited number of patients, is 3750 mg. Patients who respond to lanthanum therapy, usually achieve acceptable serum phosphate levels at doses of 1500-3000 mg lanthanum per day.

Patients with renal insufficiency may develop hypocalcaemia. Serum calcium levels should therefore be monitored at regular time intervals for this patient population and appropriate supplements given.

Dosage considerations

Lanthanum should be taken with or immediately after food, with the daily dose divided between meals. Patients should adhere to recommended diets in order to control phosphate and fluid intake.

Active ingredient

Lanthanum

Lanthanum is indicated as a phosphate binding agent for use in the control of hyperphosphataemia.

Read more about Lanthanum

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.